Viewing Study NCT06830018

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-07-02 @ 1:12 AM
Study NCT ID: NCT06830018
Status: RECRUITING
Last Update Posted: 2025-02-17
First Post: 2025-02-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer-related fatigue， cancer-caused fatigue，fatigue，appetite stimulants View
None gastric cancer，colorectal cancer，gastrointestinal tumor，cancer，tumor，carcinoma， View
None nano-crystalline megestrol acetate，megestrol，megestrol acetate， View
None antineoplastic agents, hormonal，central nervous system stimulants，appetite stimulants View